Jeff Yass’s Sunshine Biopharma Inc Warrant SBFMW Stock Holding History

Jeff Yass’s Portfolio SBFMW Stock Details SBFMW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,302	Closed	-$5.91K	–	12849
2023 Q2	$5.91K	Sell	12,302 -12,154	-50%	-$5.46K	﹤0.01%	11812
2023 Q1	$12.2K	Sell	24,456 -14,753	-38%	-$7.7K	﹤0.01%	12169
2022 Q4	$12.2K	Sell	39,209 -5,376	-12%	-$2.57K	﹤0.01%	11903
2022 Q3	$16K	Sell	44,585 -2,272	-5%	-$1.68K	﹤0.01%	12675
2022 Q2	$38K	Buy	+46,857	New	+$82.8K	﹤0.01%	12119

Other funds holding SBFMW

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jeff Yass's SBFMW Position: Q3 2023 in Review

Jeff Yass sold out of Sunshine Biopharma Inc Warrant (SBFMW) in Q3 2023, closing a stake of 12,302 shares — an estimated $5.91K sold.

Jeff Yass first reported a position in SBFMW in Q2 2022 and held it in 5 quarters. The position peaked at $38K in Q2 2022. 4 funds tracked by Wall St. Rank hold SBFMW as of Q3 2023.

Jeff Yass reported no remaining Sunshine Biopharma Inc Warrant position as of Q3 2023 after selling out during the quarter.
Jeff Yass sold 12,302 Sunshine Biopharma Inc Warrant shares in Q3 2023, an estimated $5.91K.
Jeff Yass first reported a position in Sunshine Biopharma Inc Warrant in Q2 2022 and held it in 5 quarters.
Jeff Yass's Sunshine Biopharma Inc Warrant position peaked at $38K in Q2 2022.
4 funds tracked by Wall St. Rank held Sunshine Biopharma Inc Warrant as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.